Gardner Russo & Quinn’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-8,320
Closed -$232K 89
2021
Q1
$232K Buy
8,320
+76
+0.9% +$2.02K ﹤0.01% 84
2020
Q4
$204K Buy
+8,244
New +$196K ﹤0.01% 88
2019
Q2
Sell
-6,416
Closed -$238K 97
2019
Q1
$238K Buy
+6,416
New +$233K ﹤0.01% 81
2018
Q4
Sell
-6,466
Closed -$255K 90
2018
Q3
$255K Buy
6,466
+37
+0.6% +$1.62K ﹤0.01% 82
2018
Q2
$285K Buy
6,429
+21
+0.3% +$1.04K ﹤0.01% 83
2018
Q1
$312K Buy
6,408
+20
+0.3% +$1K ﹤0.01% 82
2017
Q4
$320K Sell
6,388
-391
-6% -$20.5K ﹤0.01% 84
2017
Q3
$343K Hold
6,779
﹤0.01% 82
2017
Q2
$257K Hold
6,779
﹤0.01% 89
2017
Q1
$261K Buy
+6,779
New +$204K ﹤0.01% 88

Other funds holding CC

Gardner Russo & Quinn's CC Position: Q2 2021 in Review

Gardner Russo & Quinn sold out of Chemours (CC) in Q2 2021, closing a stake of 8,320 shares — an estimated $232K sold.

Gardner Russo & Quinn first reported a position in CC in Q1 2017 and held it in 10 quarters. The position peaked at $343K in Q3 2017. 449 funds tracked by Wall St. Rank hold CC as of Q2 2021.

  • Gardner Russo & Quinn reported no remaining Chemours position as of Q2 2021 after selling out during the quarter.
  • Gardner Russo & Quinn sold 8,320 Chemours shares in Q2 2021, an estimated $232K.
  • Gardner Russo & Quinn first reported a position in Chemours in Q1 2017 and held it in 10 quarters.
  • Gardner Russo & Quinn's Chemours position peaked at $343K in Q3 2017.
  • 449 funds tracked by Wall St. Rank held Chemours as of Q2 2021.

Based on Gardner Russo & Quinn's 13F filing for Q2 2021, filed 12 Aug 2021.